Gonzalo de Miquel
VP, Therapy Area Head, Bone Metabolism, Rare Tumours and Cell Therapy
Gonzalo De Miquel is a highly accomplished executive in the biopharmaceutical industry, specialising in clinical development and global strategy. With a strong medical background in internal medicine and a focus on respiratory and autoimmune diseases, he has successfully led numerous product developments from pre-clinical stages through to regulatory approvals. His leadership roles at Alexion Pharmaceuticals and AstraZeneca highlight his expertise in managing large teams and overseeing complex projects. Notably, he established a new Global Development organisation in Barcelona, demonstrating his entrepreneurial mindset and strategic insight. Gonzalo’s experience also extends to board positions, where he contributes to scientific committees and governance. He is committed to advancing healthcare through innovative solutions and market access strategies. His academic achievements, including a diploma from Harvard Medical School, further underscore his dedication to continuous learning and professional growth.